Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Times Interest Earned (2023 - 2025)

Inhibrx Biosciences (INBX) has disclosed Times Interest Earned for 3 consecutive years, with -$10.63 as the latest value for Q3 2025.

  • On a quarterly basis, Times Interest Earned changed N/A to -$10.63 in Q3 2025 year-over-year; TTM through Sep 2025 was -$17.09, a 1.61% decrease, with the full-year FY2024 number at -$24.57, down 256.83% from a year prior.
  • Times Interest Earned was -$10.63 for Q3 2025 at Inhibrx Biosciences, down from -$8.72 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$5.62 in Q3 2023 to a low of -$30.01 in Q2 2024.
  • A 3-year average of -$12.89 and a median of -$10.18 in 2023 define the central range for Times Interest Earned.
  • Biggest YoY gain for Times Interest Earned was 70.95% in 2025; the steepest drop was 75.7% in 2025.
  • Inhibrx Biosciences' Times Interest Earned stood at -$10.18 in 2023, then plummeted by 194.68% to -$30.01 in 2024, then surged by 64.58% to -$10.63 in 2025.
  • Per Business Quant, the three most recent readings for INBX's Times Interest Earned are -$10.63 (Q3 2025), -$8.72 (Q2 2025), and -$15.95 (Q1 2025).